Papers
2
Total Citations
123
H-Index
2
About
Francesco Bertagna is a leading urologic surgeon and clinical researcher whose work centers on optimizing surgical outcomes in robot-assisted partial nephrectomy (RAPN) for kidney cancer. His primary research areas include renal function preservation, warm ischemia time (WIT), and the comparative effectiveness of on-clamp versus off-clamp surgical techniques. Bertagna’s major contribution is his central role in the landmark CLOCK trial (NCT02287987), a multicenter randomized controlled trial that rigorously compared functional outcomes between on- and off-clamp RAPN. His 2021 paper from this trial, cited over 100 times, provided pivotal evidence that off-clamp RAPN may better preserve renal function. He further advanced the field with a 2023 study using radionuclide renal scans to precisely quantify the impact of WIT on postoperative kidney function, offering objective, high-resolution data that challenged conventional assumptions. With his work accumulating hundreds of citations and shaping international guidelines, Bertagna has established himself as a key voice in nephron-sparing surgery. His research is essential reading for any urologist or trainee seeking evidence-based strategies to balance oncologic control with maximal renal preservation.
Research Focus
Key Achievements
Top Papers
- 1
- 2